CYP1A2 is an enzyme primarily involved in metabolizing caffeine and certain medications. There is no strong scientific evidence that CYP1A2 directly helps with stress. An indirect link may exist via caffeine metabolism: individuals with a slow CYP1A2 variant break down caffeine more slowly, which can lead to jitteriness, sleep disruption, and heightened stress perception with high intake. Conversely, a fast variant might allow better caffeine tolerance. However, effects are highly individual and influenced by many factors. Consumer DNA tests provide only suggestive insights, not a medical diagnosis. Stress management should rely on proven approaches like exercise, sleep hygiene, and possibly psychological counseling – not on a single gene. Evidence: mechanistic/unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-6e02b879d0d70e24f6bdc5ad